CADTH Canadian Drug Expert Committee Final Recommendation Sapropterin — Resubmission: (Kuvan — BioMarin Pharmaceuticals Canada Inc.): Indication: To reduce blood phenylalanine levels in patients with hyperphenylalaninemia due to BH4-responsive phenylketonuria [Internet].